Insulet
OmniPod | A convenient way to help manage diabetes.
Launch date
Employees
Market cap
AUD25.0b
Enterprise valuation
AUD25.9b (Public information from Sep 2024)
Share price
$236.11 PODD
Acton Massachusetts (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 904m | 1.1b | 1.3b | 1.7b | 2.0b | 2.4b | 2.8b |
% growth | 23 % | 21 % | 19 % | 30 % | 19 % | 18 % | 18 % |
EBITDA | 54.8m | 124m | 36.5m | 324m | 424m | 520m | 638m |
% EBITDA margin | 6 % | 11 % | 3 % | 19 % | 21 % | 22 % | 23 % |
Profit | 6.8m | 16.8m | 4.6m | 206m | 379m | 286m | 365m |
% profit margin | 1 % | 2 % | - | 12 % | 19 % | 12 % | 13 % |
EV / revenue | 18.7x | 17.1x | 16.2x | 9.3x | 7.3x | 6.0x | 5.0x |
EV / EBITDA | 309.3x | 151.6x | 580.0x | 49.0x | 34.6x | 27.7x | 22.0x |
R&D budget | 147m | 160m | 180m | 205m | - | - | - |
R&D % of revenue | 16 % | 15 % | 14 % | 12 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
$1.0m | Seed | ||
$980k | Series A | ||
$35.5m | Series D | ||
* | $50.0m | Late VC | |
$50.9m | Series E | ||
N/A | N/A | IPO | |
* | $3.4m | Post IPO Equity | |
Total Funding | AUD214m |
Related Content
Recent News about Insulet
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Insulet
EditACQUISITION by Insulet Jun 2011